Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 12:02 PM ET

Capital Markets

Company Overview of AGLAIA BioMedical Ventures B.V.

Company Overview

Aglaia Biomedical Ventures B.V. is a private equity and venture capital firm specializing in investments in incubation, startup, early stage, PIPEs, bridge financing, companies. It focuses on investments in tools and technologies as well as components of contemporary drug development in biomedical companies in the field of oncology and in biotechnology companies. It invests in companies offering therapies for the prevention and cure of cancer. It usually invests in companies based in Europe. The firm typically invests up to EUR8 million (USD10.28 million) in the companies. It prefers to take an active role in the strategic and operational processes of its portfolio companies. Aglaia Biomedic...

Businesspark Berg & Bosch

Professor Bronkhorstlaan 10, building 92

Bilthoven,  3723 MB

Netherlands

Founded in 2003

Phone:

31 30 229 6090

Fax:

31 30 229 6099

Key Executives for AGLAIA BioMedical Ventures B.V.

Compensation as of Fiscal Year 2015.

AGLAIA BioMedical Ventures B.V. Key Developments

AGLAIA BioMedical Ventures B.V. Presents at BIO-Europe 2015, Nov-02-2015

AGLAIA BioMedical Ventures B.V. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

AGLAIA BioMedical Ventures B.V. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

AGLAIA BioMedical Ventures B.V. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 14, 2015
Inthera Bioscience AG
Private Placement
October 29, 2015
InteRNA Technologies B.V.
Private Placement
August 26, 2015
Merus B.V.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AGLAIA BioMedical Ventures B.V., please visit www.aglaia-biomedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.